Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine Oral Care for Ventilator-Associated Respiratory Complications
NCT04505202Completed
- Sponsor
- Karabük University
- Start
- Apr 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of chlorhexidine in ventilator-associated pneumonia (VAP) and ventilator-associated tracheobronchitis (VAT) (2 arms), sponsored by Karabük University. Primary endpoints: Pathogen colonization change at Day 3, Oral Assessment Guide Score at Day 3 and 2 more. Started Apr 2019; status: completed.
02
Drugs
chlorhexidine
03
Conditions
ventilator-associated pneumonia (VAP)ventilator-associated tracheobronchitis (VAT)
Beyond the preview
Go deeper on NCT04505202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505202.